|
1
|
Boulton A: Strengthening the international
diabetes federation (IDF). Diabetes Res Clin Pract.
160(108029)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhu WW, Yang HX, Wang C, Su RN, Feng H and
Kapur A: High prevalence of gestational diabetes mellitus in
beijing: Effect of maternal birth weight and other risk factors.
Chin Medical J (Engl). 130:1019–1025. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bellamy L, Casas JP, Hingorani AD and
Williams D: Type 2 diabetes mellitus after gestational diabetes: A
systematic review and meta-analysis. Lancet. 373:1773–1779.
2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Alejandro EU, Mamerto TP, Chung G,
Villavieja A, Gaus NL, Morgan E and Pineda-Cortel MRB: Gestational
diabetes mellitus: A harbinger of the vicious cycle of diabetes.
Int J Mol Sci. 21(5003)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Diagnostic criteria and classification of
hyperglycaemia first detected in pregnancy: A World Health
Organization Guideline. Diabetes Res Clin Pract. 103:341–363.
2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Samuel VT and Shulman GI: The pathogenesis
of insulin resistance: Integrating signaling pathways and substrate
flux. J Clin Invest. 126:12–22. 2016.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Ebner M, Lucic I, Leonard TA and Yudushkin
I: PI(3,4,5)P3 Engagement restricts Akt activity to cellular
membranes. Mol Cell. 65:416–431.e6. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ashcroft FM and Rorsman P: Diabetes
mellitus and the β cell: The last ten years. Cell. 148:1160–1171.
2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Prieto D, Contreras C and Sanchez A:
Endothelial dysfunction, obesity and insulin resistance. Curr Vasc
Pharmacol. 12:412–426. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
McGarry JD and Dobbins RL: Fatty acids,
lipotoxicity and insulin secretion. Diabetologia. 42:128–138.
1999.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Donath MY, Schumann DM, Faulenbach M,
Ellingsgaard H, Perren A and Ehses JA: Islet inflammation in type 2
diabetes: From metabolic stress to therapy. Diabetes Care. 31
(Suppl 2):S161–S164. 2008.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Weir GC, Marselli L, Marchetti P, Katsuta
H, Jung MH and Bonner-Weir S: Towards better understanding of the
contributions of overwork and glucotoxicity to the beta-cell
inadequacy of type 2 diabetes. Diabetes Obes Metab. 11 (Suppl
4):S82–S90. 2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Busch AK, Cordery D, Denyer GS and Biden
TJ: Expression profiling of palmitate- and oleate-regulated genes
provides novel insights into the effects of chronic lipid exposure
on pancreatic beta-cell function. Diabetes. 51:977–987.
2002.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Shukla GC, Singh J and Barik S: MicroRNAs:
Processing, maturation, target recognition and regulatory
functions. Mol Cell Pharmacol. 3:83–92. 2011.PubMed/NCBI
|
|
16
|
Ma J, Wang J, Liu Y, Wang C, Duan D, Lu N,
Wang K, Zhang L, Gu K, Chen S, et al: Comparisons of serum miRNA
expression profiles in patients with diabetic retinopathy and type
2 diabetes mellitus. Clinics (Sao Paulo). 72:111–115.
2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sebastiani G, Guarino E, Grieco GE,
Formichi C, Poggi CD, Ceccarelli E and Dotta F: Circulating
microRNA (miRNA) expression profiling in plasma of patients with
gestational diabetes mellitus reveals upregulation of miRNA
miR-330-3p. Front Endocrinol (Lausanne). 8(345)2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhao C, Dong J, Jiang T, Shi Z, Yu B, Zhu
Y, Chen D, Xu J, Huo R, Dai J, et al: Early second-trimester serum
miRNA profiling predicts gestational diabetes mellitus. PLoS One.
6(e23925)2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Collares CV, Evangelista AF, Xavier DJ,
Rassi DM, Arns T, Foss-Freitas MC, Foss MC, Puthier D,
Sakamoto-Hojo ET, Passos GA and Donadi EA: Identifying common and
specific microRNAs expressed in peripheral blood mononuclear cell
of type 1, type 2, and gestational diabetes mellitus patients. BMC
Res Notes. 6(491)2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Du H, Yin Z, Zhao Y, Li H, Dai B, Fan J,
He M, Nie X, Wang CY, Wang DW and Chen C: miR-320a induces
pancreatic beta cells dysfunction in diabetes by inhibiting MafF.
Mol Ther Nucleic Acids. 26:444–457. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Fan L, Shan A, Su Y, Cheng Y, Ji H, Yang
Q, Lei Y, Liu B, Wang W, Ning G, et al: MiR-221/222 inhibit insulin
production of pancreatic beta-cells in mice. Endocrinology.
161(bqz027)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang P, Wang H, Li C, Zhang X, Xiu X, Teng
P and Wang Z: Dysregulation of microRNA-657 influences inflammatory
response via targeting interleukin-37 in gestational diabetes
mellitus. J Cell Physiol. 234:7141–7148. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wang P and Wang Z, Liu G, Jin C, Zhang Q,
Man S and Wang Z: MiR-657 promotes macrophage polarization toward
M1 by targeting FAM46C in gestational diabetes mellitus. Mediators
Inflamma. 2019(4851214)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zheng Y, Wang Z, Tu Y, Shen H, Dai Z, Lin
J and Zhou Z: miR-101a and miR-30b contribute to inflammatory
cytokine-mediated beta-cell dysfunction. Lab Invest. 95:1387–1397.
2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhang H, Luan S, Xiao X, Lin L, Zhao X and
Liu X: Silenced microRNA-222 suppresses inflammatory response in
gestational diabetes mellitus mice by promoting CXCR4. Life Sci.
266(118850)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang F, Li Z, Zhao M, Ye W, Wu H, Liao Q,
Bu S and Zhang Y: Circulating miRNAs miR-574-5p and miR-3135b are
potential metabolic regulators for serum lipids and blood glucose
in gestational diabetes mellitus. Gynecol Endocrinol. 37:665–671.
2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Smyth GK: Linear models and empirical
bayes methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol. 3(Article3)2004.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Weinert LS: International association of
diabetes and pregnancy study groups recommendations on the
diagnosis and classification of hyperglycemia in pregnancy: Comment
to the international association of diabetes and pregnancy study
groups consensus panel. Diabetes Care. 33(e97): author reply e98.
2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
International Association of Diabetes and
Pregnancy Study Groups Consensus Panel. Metzger BE, Gabbe SG,
Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, de Leiva A,
Hod M, et al: International association of diabetes and pregnancy
study groups recommendations on the diagnosis and classification of
hyperglycemia in pregnancy. Diabetes Care. 33:676–682.
2010.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhao H and Tao S: MiRNA-221 protects islet
beta cell function in gestational diabetes mellitus by targeting
PAK1. Biochem Biophys Res Commun. 520:218–224. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wen J, Han S, Cui M and Wang Y:
[Retracted] long noncoding RNA MCM3APAS1 drives ovarian cancer
progression via the microRNA1433p/TAK1 axis. Oncol Rep.
46(178)2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Wei L, Cao C, Ma X, Wang X, Wang M and
Zhang P: Elevated serum and urine MiR-429 contributes to the
progression of gestational diabetes mellitus. Clin Lab.
67:10.7754/Clin.Lab.2020.200909. 2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wen J and Bai X: miR-520h Inhibits cell
survival by targeting mTOR in gestational diabetes mellitus. Acta
Biochim Pol. 68:65–70. 2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Muralimanoharan S, Maloyan A and Myatt L:
Mitochondrial function and glucose metabolism in the placenta with
gestational diabetes mellitus: Role of miR-143. Clin Sci (Lond).
130:931–941. 2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhang JT, Cai QY, Ji SS, Zhang HX, Wang
YH, Yan HT and Yang XJ: Decreased miR-143 and increased miR-21
placental expression levels are associated with macrosomia. Mol Med
Rep. 13:3273–3280. 2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Wang Y, Li H, Shi Y, Wang S, Xu Y, Li H
and Liu D: miR-143-3p impacts on pulmonary inflammatory factors and
cell apoptosis in mice with mycoplasmal pneumonia by regulating
TLR4/MyD88/NF-kappaB pathway. Biosci Rep.
40(BSR20193419)2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Tu H, Chen D, Cai C, Du Q, Lin H, Pan T,
Sheng L, Xu Y, Teng T, Tu J, et al: microRNA-143-3p attenuated
development of hepatic fibrosis in autoimmune hepatitis through
regulation of TAK1 phosphorylation. J Cell Mol Med. 24:1256–1267.
2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Hajifaraji M, Jahanjou F, Abbasalizadeh F,
Aghamohammadzadeh N, Abbasi MM and Dolatkhah N: Effect of probiotic
supplements in women with gestational diabetes mellitus on
inflammation and oxidative stress biomarkers: A randomized clinical
trial. Asia Pac J Clin Nutr. 27:581–591. 2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Sha H, Zeng H, Zhao J and Jin H:
Mangiferin ameliorates gestational diabetes mellitus-induced
placental oxidative stress, inflammation and endoplasmic reticulum
stress and improves fetal outcomes in mice. Eur J Pharmacol.
859(172522)2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Zhang Y, Qu L, Ni H, Wang Y, Li L, Yang X,
Wang X and Hou Y: Expression and function of lncRNA MALAT1 in
gestational diabetes mellitus. Adv Clin Exp Med. 29:903–910.
2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Kuzmicki M, Telejko B,
Wawrusiewicz-Kurylonek N, Lipinska D, Pliszka J, Wilk J, Zielinska
A, Skibicka J, Szamatowicz J, Kretowski A and Gorska M: The
expression of genes involved in NF-kappaB activation in peripheral
blood mononuclear cells of patients with gestational diabetes. Eur
J Endocrinol. 168:419–427. 2013.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Elliott HR, Sharp GC, Relton CL and Lawlor
DA: Epigenetics and gestational diabetes: A review of epigenetic
epidemiology studies and their use to explore epigenetic mediation
and improve prediction. Diabetologia. 62:2171–2178. 2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Chen SH, Liu XN and Peng Y: MicroRNA-351
eases insulin resistance and liver gluconeogenesis via the PI3K/AKT
pathway by inhibiting FLOT2 in mice of gestational diabetes
mellitus. J Cell Mol Med. 23:5895–5906. 2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Pfeiffer S, Sanchez-Lechuga B, Donovan P,
Halang L, Prehn JHM, Campos-Caro A, Byrne MM and López-Tinoco C:
Circulating miR-330-3p in late pregnancy is associated with
pregnancy outcomes among lean women with GDM. Sci Rep.
10(908)2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Fu S, Fu S, Ma X, Yang X and Ling J:
miR8755p regulates IR and inflammation via targeting TXNRD1 in
gestational diabetes rats. Mol Med Rep. 23(303)2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Hromadnikova I, Kotlabova K, Dvorakova L
and Krofta L: Diabetes mellitus and cardiovascular risk assessment
in mothers with a history of gestational diabetes mellitus based on
postpartal expression profile of microRNAs associated with diabetes
mellitus and cardiovascular and cerebrovascular diseases. Int J Mol
Sci. 21(2437)2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Yu B, Zhao Y, Zhang H, Xie D, Nie W and
Shi K: Inhibition of microRNA-143-3p attenuates myocardial
hypertrophy by inhibiting inflammatory response. Cell Biol Int.
42:1584–1593. 2018.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Cai XJ, Huang LH, Zhu YK and Huang YJ:
LncRNA OIP5AS1 aggravates house dust miteinduced inflammatory
responses in human bronchial epithelial cells via the
miR1433p/HMGB1 axis. Mol Med Rep. 22:4509–4518. 2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Lin X, Du Y, Lu W, Gui W, Sun S, Zhu Y,
Wang G, Eserberg DT, Zheng F, Zhou J, et al: CircRNF111 protects
against insulin resistance and lipid deposition via regulating
miR-143-3p/IGF2R axis in metabolic syndrome. Front Cell Dev Biol.
9(663148)2021.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Ajibade AA, Wang HY and Wang RF: Cell
type-specific function of TAK1 in innate immune signaling. Trends
Immunol. 34:307–316. 2013.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Delaney JR and Mlodzik M: TGF-beta
activated kinase-1: New insights into the diverse roles of TAK1 in
development and immunity. Cell Cycle. 5:2852–2855. 2006.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Fan Y, Yu Y, Mao R, Zhang H and Yang J:
TAK1 Lys-158 but not Lys-209 is required for IL-1beta-induced
Lys63-linked TAK1 polyubiquitination and IKK/NF-κB activation. Cell
Signal. 23:660–665. 2011.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Hayden MS and Ghosh S: Shared principles
in NF-kappaB signaling. Cell. 132:344–362. 2008.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Karin M and Ben-Neriah Y: Phosphorylation
meets ubiquitination: The control of NF-[kappa]B activity. Ann Rev
Immunol. 18:621–663. 2000.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Lee JH, Lee JH and Rane SG: TGF-β
signaling in pancreatic islet β cell development and function.
Endocrinology. 162(bqaa233)2021.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Ardestani A and Maedler K: The hippo
signaling pathway in pancreatic β-cells: Functions and regulations.
Endocr Rev. 39:21–35. 2018.PubMed/NCBI View Article : Google Scholar
|
